DRW Securities LLC Acquires Shares of 13,269 Aflac Incorporated (NYSE:AFL)

DRW Securities LLC acquired a new stake in shares of Aflac Incorporated (NYSE:AFL) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 13,269 shares of the financial services provider’s stock, valued at approximately $1,186,000.

Several other hedge funds have also recently modified their holdings of the stock. Dimensional Fund Advisors LP increased its holdings in Aflac by 6.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock valued at $429,319,000 after acquiring an additional 285,576 shares during the last quarter. ProShare Advisors LLC grew its position in shares of Aflac by 5.6% during the second quarter. ProShare Advisors LLC now owns 2,220,125 shares of the financial services provider’s stock valued at $198,279,000 after purchasing an additional 117,504 shares in the last quarter. Nordea Investment Management AB increased its holdings in shares of Aflac by 6.7% in the first quarter. Nordea Investment Management AB now owns 1,806,475 shares of the financial services provider’s stock worth $155,140,000 after purchasing an additional 113,226 shares during the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Aflac by 27.6% in the second quarter. Envestnet Asset Management Inc. now owns 1,243,189 shares of the financial services provider’s stock worth $111,029,000 after buying an additional 268,694 shares in the last quarter. Finally, Captrust Financial Advisors boosted its stake in Aflac by 0.7% during the first quarter. Captrust Financial Advisors now owns 980,236 shares of the financial services provider’s stock valued at $84,163,000 after buying an additional 7,163 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Trading Up 0.0 %

Shares of NYSE AFL opened at $107.92 on Monday. Aflac Incorporated has a fifty-two week low of $74.89 and a fifty-two week high of $111.14. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10. The company has a market cap of $61.32 billion, a price-to-earnings ratio of 11.91, a PEG ratio of 2.53 and a beta of 0.95. The business’s 50 day moving average price is $102.88 and its 200-day moving average price is $92.03.

Aflac (NYSE:AFL) last released its earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.23. The business had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The business’s revenue for the quarter was down .7% compared to the same quarter last year. During the same period last year, the company earned $1.58 earnings per share. On average, sell-side analysts expect that Aflac Incorporated will post 6.75 earnings per share for the current year.

Aflac Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Shareholders of record on Wednesday, August 21st were paid a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $2.00 dividend on an annualized basis and a yield of 1.85%. Aflac’s dividend payout ratio is currently 22.08%.

Analysts Set New Price Targets

A number of research firms have issued reports on AFL. Jefferies Financial Group reduced their price objective on Aflac from $84.00 to $83.00 and set a “hold” rating on the stock in a research note on Friday, June 28th. Morgan Stanley boosted their price target on shares of Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research report on Monday, August 19th. JPMorgan Chase & Co. increased their price objective on shares of Aflac from $80.00 to $83.00 and gave the company a “neutral” rating in a research report on Tuesday, July 2nd. Barclays began coverage on shares of Aflac in a report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 target price on the stock. Finally, UBS Group increased their price target on shares of Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a report on Wednesday, August 14th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $92.50.

Insider Transactions at Aflac

In related news, Director Thomas J. Kenny sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the sale, the director now owns 18,158 shares in the company, valued at $1,796,552.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.90% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.